Efficacy and Safety of HIP1601 Capsule

Clinical trial NCT04080726 · COMPLETED

Trial details

NCT number: NCT04080726
Sponsor: Hanmi Pharmaceutical Company Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Erosive Gastroesophageal Reflux Disease

Start date: 2018-10-25
Primary completion: 2019-12-03
Enrollment: 213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.